Skip to content

Effect of Tapta guda agnikarma in Vatakantaka

A Controlled Clinical Study To Evaluate The Efficacy Of Tapta Guda And Rajata Shalaka Agnikarma In The Management Of Vatakantaka (Plantar Fasciitis) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104575
Enrollment
40
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

None listed

Sponsors

Dr Lendave Sourabh Sarjerao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient clinically diagnosed with signs and symptoms of Vatakantaka like Parshni shoola and Sthamba and Sparshasahatva 2. Patient with Flat foot (Pes Planus) / High arches (Pes Cavus) 3. Calcanea spur associated with Plantar fasciitis 4. Patient will be selected irrespective of Gender, Religion, Socio-economic status.

Exclusion criteria

Exclusion criteria: 1. Patient with Pressure ulcer on heel 2. Calcaneal fracture 3. Patients with Known case of Diabetes Mellitus and Hypertension and on Anti- Platelet drugs 4. Patient with PVD, PND 5. Pregnant Women and Lactating Mothers

Design outcomes

Primary

MeasureTime frame
Effect of Trial Drug on improvement in the symptoms of Vatakantaka (Plantar Fasciitis)Timepoint: 1st Day, 3rd Day, 5th Day, 7th Day.

Secondary

MeasureTime frame
Safety of trial drug & adverse drug reaction & aggravation of symptoms of Vatakantaka (Plantar Fasciitis)Timepoint: 1st Day, 3rd Day, 5th Day, 7th Day

Countries

India

Contacts

Public ContactDr Sujata B Waddar

SDMTs AMC Post Graduation Centre Terdal

sujata.bw@gmail.com8105401470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026